QFC
Mezigdomide
Created: | 2022-06-08 |
Last modified: | 2022-07-20 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 72 |
Chiral Atom Count | 1 |
Bond Count | 77 |
Aromatic Bond Count | 18 |
Chemical Component Summary | |
---|---|
Name | Mezigdomide |
Systematic Name (OpenEye OEToolkits) | 4-[4-[[4-[[2-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-1-oxidanylidene-3~{H}-isoindol-4-yl]oxymethyl]phenyl]methyl]piperazin-1-yl]-3-fluoranyl-benzenecarbonitrile |
Formula | C32 H30 F N5 O4 |
Molecular Weight | 567.61 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | O=C1NC(=O)CCC1N1Cc2c(cccc2OCc2ccc(cc2)CN2CCN(CC2)c2ccc(C#N)cc2F)C1=O |
SMILES | CACTVS | 3.385 | Fc1cc(ccc1N2CCN(CC2)Cc3ccc(COc4cccc5C(=O)N(Cc45)[CH]6CCC(=O)NC6=O)cc3)C#N |
SMILES | OpenEye OEToolkits | 2.0.7 | c1cc2c(c(c1)OCc3ccc(cc3)CN4CCN(CC4)c5ccc(cc5F)C#N)CN(C2=O)C6CCC(=O)NC6=O |
Canonical SMILES | CACTVS | 3.385 | Fc1cc(ccc1N2CCN(CC2)Cc3ccc(COc4cccc5C(=O)N(Cc45)[C@H]6CCC(=O)NC6=O)cc3)C#N |
Canonical SMILES | OpenEye OEToolkits | 2.0.7 | c1cc2c(c(c1)OCc3ccc(cc3)CN4CCN(CC4)c5ccc(cc5F)C#N)CN(C2=O)[C@H]6CCC(=O)NC6=O |
InChI | InChI | 1.03 | InChI=1S/C32H30FN5O4/c33-26-16-23(17-34)8-9-27(26)37-14-12-36(13-15-37)18-21-4-6-22(7-5-21)20-42-29-3-1-2-24-25(29)19-38(32(24)41)28-10-11-30(39)35-31(28)40/h1-9,16,28H,10-15,18-20H2,(H,35,39,40)/t28-/m0/s1 |
InChIKey | InChI | 1.03 | YTINZZFBHWSAGL-NDEPHWFRSA-N |
Drug Info: DrugBank
DrugBank ID | DB17584 |
---|---|
Name | Mezigdomide |
Groups | investigational |
Description | Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma). |
Synonyms |
|
CAS number | 2259648-80-9 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 137379043 |
ChEMBL | CHEMBL4648616 |